Knowledge Sharing, and Training Are Critical for Future Success Pharmacometrics as a Discipline Is Entering the ''Industrialization'' Phase: Standards, Automation,

http://jcp.sagepub.com/content/50/9_suppl/9S The online version of this article can be found at: DOI: 10.1177/0091270010377788 2010 50: 9S J Clin Pharmacol R. Gastonguay, Bernd Meibohm and Hartmut Derendorf Klaus Romero, Brian Corrigan, Christoffer W. Tornoe, Jogarao V. Gobburu, Meindert Danhof, William R. Gillespie, Marc Knowledge Sharing, and Training Are Critical for Future Success Pharmacometrics as a Discipline Is Entering the ''Industrialization'' Phase: Standards, Automation,

[1]  J. Woodcock.  Precompetitive Research: A New Prescription for Drug Development? , 2010, Clinical pharmacology and therapeutics.

[2]  K. Romero,et al.  The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer's and Parkinson's Diseases , 2009, Clinical pharmacology and therapeutics.

[3]  B P Booth,et al.  Elucidation of Relationship Between Tumor Size and Survival in Non‐Small‐Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development , 2009, Clinical pharmacology and therapeutics.

[4]  Ohidul Siddiqui,et al.  Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease , 2009, The AAPS Journal.

[5]  Meindert Danhof,et al.  Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. , 2007, Annual review of pharmacology and toxicology.

[6]  Liping Zhang,et al.  The current role of model-based drug development , 2010, Expert opinion on drug discovery.

[7]  Yaning Wang,et al.  Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications , 2005, The AAPS Journal.

[8]  B. Ploeger,et al.  Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. , 2008, Trends in pharmacological sciences.

[9]  F. Goodsaid,et al.  The Critical Path Institute's Approach to Precompetitive Sharing and Advancing Regulatory Science , 2010, Clinical pharmacology and therapeutics.

[10]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[11]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[12]  Marc R Gastonguay,et al.  Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings , 2008, Journal of clinical pharmacology.

[13]  Meindert Danhof,et al.  Disease System Analysis: Basic Disease Progression Models in Degenerative Disease , 2005, Pharmaceutical Research.

[14]  W Ewy,et al.  Model‐based Drug Development , 2007, Clinical pharmacology and therapeutics.

[15]  Matthew M Riggs,et al.  A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling. , 2010, Bone.

[16]  Brian Corrigan,et al.  Population Dose-Response Model for ADAS-cog Scores in Patients with Alzheimers Disease by Meta-Analysis of a Mixture of Summary and Individual Data , 2009 .

[17]  M. Gastonguay,et al.  Mathematics for Understanding Disease , 2008, Clinical pharmacology and therapeutics.

[18]  Marc Pfister,et al.  Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development , 2008, The AAPS Journal.

[19]  Meindert Danhof,et al.  Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. , 2009, Drug discovery today.

[20]  L. Lesko,et al.  Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision? , 2007, Clinical pharmacology and therapeutics.

[21]  C Garnett,et al.  Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006 , 2007, Clinical pharmacology and therapeutics.

[22]  Vikram Sinha,et al.  Model-Based Drug Development: The Road to Quantitative Pharmacology , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[23]  N. Holford,et al.  Time for Quantitative Clinical Pharmacology: A Proposal for a Pharmacometrics Curriculum , 2007, Clinical pharmacology and therapeutics.

[24]  Lawrence J Lesko,et al.  Quantitative disease, drug, and trial models. , 2009, Annual review of pharmacology and toxicology.